For information about COVID-19 testing and care, vaccination, and visitor guidelines at Duke please visit www.dukehealth.org.
Cancer Prevention is the Ultimate Therapy.
Looking to the Next Half Century
As Duke celebrates its 50th anniversary of cancer discovery and care, researchers and providers envision the future.
Meet the mom and daughter who lit the virtual Tree of Hope at the Duke Cancer Patient Support Programʼs 31st annual Tree of Hope Lighting Ceremony.
Race, and how people are treated differently because of it, leads to major differences in health outcomes for cancer. Tomi Akinyemiju, PhD, has built her career examining these disparities so we can learn how to fix them.
Donor support is helping more men receive screening, education, and follow-up care to detect and treat prostate cancer earlier, when it's more curable.
"Sometimes we have to go on a journey we don't want to go on. But I'm getting better," said breast cancer survivor Vennice Roberts.
A gift from the family of pancreatic cancer survivor Nancy Wright helps spread the sound of hope in the Duke cancer community.
We all know that exercise is good for us. But what if doctors could prescribe the precise workout that would help each person beat their cancer?
Good news about Duke Cancer Institute's continued recognition as a leader in cancer research and care, and new investments in immunotherapy.
Translating Findings from a lab into patients in a clinic can be a long slog up a steep hill. The new DCI Center for Cancer Immunotherapy helps researchers with the climb.
Duke alumnus Ross Bierkan has long supported his alma mater. But his support of melanoma research at Duke is motivated by personal experience.
Most studies of new treatments don't reflect the diversity of people in the real world. That's a problem our researchers are finding new ways to solve.
Some of the newest and most exciting cancer treatments don’t work for everybody. Instead, they target tumors that have a specific genetic mutation or characteristic.
Nancy Davenport-Ennis has survived cancer twice. One of her many strategies for thriving—look for ways to help others. Learn more about her patient advocacy.
Ever since Duke Cancer Institute helped Meg Lindenberger survive breast cancer 10 years ago, she and her husband, Bill, have been faithful supporters.
Researcher Meira Epplein partnered with Durham Pastor Ronald L. Godbee to spread the word about cancer prevention at the River Church.
Ten years, twelve years, even more than two decades. That is how long some of DCI’s patients with prostate and other urologic cancers are living past their diagnoses.
Dan George, MD, remembers one of the first times he helped someone live longer. He was treating a patient with metastatic kidney cancer.
Brant Inman, MD, MS, is skilled at the major surgeries that no one wants to be unlucky enough to have. He'd prefer to put himself out of business.
Five years after surgery to treat prostate cancer, Steele Dewey of Charlotte, North Carolina was told that the cancer had spread. He chose Dan George, MD, at Duke.
Despite living with stage 4 kidney cancer, Marisha Hargrove of Henderson, North Carolina, still sings in her church choir and takes care of her two children.
It’s something that has happened to all of us; you arrive on time for your 10:30 a.m. doctor’s appointment and wait an hour, only to have the doctor spend 15 minutes with you.
Cardiologist Chiara Melloni became interested in the emerging field of cardio-oncology after her father developed heart problems while being treated for lung cancer.
Motivated by her late husband's cancer journey, Fumiko Chino, MD, a resident in radiation oncology, studies the high cost of cancer care.
In January, DCI joined a select group of medical centers authorized to offer CAR T-cell therapy for patients with with certain types of relapsed or refractory non-Hodgkin’s lymphoma.
Why do perfectly good cancer treatments suddenly stop working? Researcher and lymphoma survivor Kris Wood is finding answers.
People diagnosed with cancer enter a period of intense treatment at a cancer center, and it can seem to their primary care physicians that they have disappeared.
Inflammatory breast cancer may hold the secret to understanding what happens when any breast cancer turns deadly, says Duke researcher Gayathri Devi, PhD.
When his dad passed away from cancer, Myles Owens IV launched a clothing line in his memory. Part of the proceeds benefit Duke Cancer Institute research.
Leslie Love, 59, has been volunteering with the Duke Cancer Patient Support Program for more than 11 years. She never thought that she would flip to the other side.
A cancer diagnosis can bring on feelings of anxiety, such as worry, fear, and sadness. For some, the feelings do not subside but worsen to affect daily life.
The executive director of the local chapter of the Susan G. Komen Foundation, Pam Kohl, is living proof that funding groundbreaking breast cancer research matters.
Dorothy Sipkins, MD, PhD, is developing a clinical trial of a new therapy that may force hidden breast cancer cells out of the bone marrow and back into the bloodstream.
As recently as ten years ago, patients with brain metastasis were rarely offered surgical treatment.It was essentially viewed as a death sentence.